LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
129 hedge funds and large institutions have $2.4B invested in Loxo Oncology, Inc in 2017 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 49 increasing their positions, 24 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding
Funds holding: 86 → 129 (+43)
63% less call options, than puts
Call options by funds: $2.09M | Put options by funds: $5.7M
Holders
129
Holding in Top 10
11
Calls
$2.09M
Puts
$5.7M
Top Buyers
| 1 | +$52.9M | |
| 2 | +$46.7M | |
| 3 | +$37.9M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$33.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$30M |
Top Sellers
| 1 | -$42.6M | |
| 2 | -$40.3M | |
| 3 | -$20.1M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.3M |